Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 19 trials

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

16Total
Not Applicable (5)
Early P 1 (2)
P 1 (8)
P 4 (1)

Trial Status

Recruiting11
Not Yet Recruiting4
Unknown2
Active Not Recruiting2

Clinical Trials (19)

Showing 19 of 19 trials
NCT06802406Not ApplicableRecruiting

Nutrition OUtReach In Systems of Healthcare

NCT06575712Not ApplicableRecruiting

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

NCT06222853Phase 1Active Not Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Refractory Systemic Lupus Erythematosus

NCT07296120Phase 4Not Yet RecruitingPrimary

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

NCT07269587Active Not Recruiting

A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

NCT07246304Early Phase 1Recruiting

TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC

NCT07198867Phase 1Recruiting

A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

NCT06553898Phase 1Recruiting

Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS

NCT07120633Not ApplicableRecruiting

Anti CD19 CAR-T Combined With BTKi to Treat Newly Diagnosed High-risk CLL/SLL

NCT06703216Phase 1Not Yet Recruiting

Pre-emptive Anakinra for Cytokine Event Reduction

NCT06842589Phase 1Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS

NCT06935136Not ApplicableNot Yet RecruitingPrimary

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

NCT06554951RecruitingPrimary

Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies

NCT06508346Recruiting

Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Refractory AAV

NCT06647329Phase 1Not Yet RecruitingPrimary

CAR-T Technology for Recurrent/Refractory Malignant Hematological and Lymphatic Tumors

NCT06196294Phase 1Recruiting

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

NCT05779917Phase 1Recruiting

Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers

NCT05858684Early Phase 1UnknownPrimary

Dual Target CAR-T Cell Treatment for Refractory Systemic Lupus Erythematosus (SLE) Patients

NCT04280133Not ApplicableUnknown

CAR T-CELL Therapy Educational Video Trial

Showing all 19 trials

Research Network

Activity Timeline